A Louisville company that’s developing a medical device to help surgeons monitor the progress of spinal fusion surgeries is eyeing a relocation to the Cleveland area.OrthoData is hoping to attract some Northeast Ohio investors to help pave the way for the relocation. The company would also use a hoped-for $7 million series B round of [...]

Wellness products seller Max-Wellness unveiled several new initiatives aimed at reaching customers outside of its retail stores. Among those initiatives: a home-care “concierge” service for seniors, smaller “mini-Max” stores in hospitals and rehabilitation centers, “wellness-in-box” vending machines with wellness products tailored to the machines’ locations and an expanded website with thousands of products.

U.S. Marshals have seized $16.5 million worth of Auralgan Otic Solution, an ear infection drug that the U.S. Food and Drug Administration says Deston Therapeutics has been marketing without approval.

The transplant medical device relies on high frequency ultrasound that monitors blood flow and the cardiovascular system, which is the first place sign of rejection will appear. The transplant monitoring system is still pending FDA approval, but it was used recently with a hand transplant at Jewish Hospital Hand Care Center and the Christine M Kleinert Institute.

Transposagen Biopharmaceuticals Inc. signed an exclusive licensing deal with Charles River Laboratories International Inc. (NYSE:CRL) for lab rats.Under the agreement, Wilmington, Mass.-based Charles River will market and distribute the Lexington, Ky.-based lab rat developer’s p53 and Bcrp TGEM Knockout rat models, so named for mutations in their p53 and Bcrp [...]

Sixteen-year-old Chrysalis Ventures saw the recent worldwide financial crisis as an opportunity to invest in Middle America.While some venture firms spent the crisis hoarding their cash, or investing more in existing portfolio companies, the Louisville, Ky., firm made seven new investments in the Midwest and South last year. That included a $4 million co-investment in [...]

Xanodyne Pharmaceuticals Inc., developer and maker of drugs for women’s health care and pain management, has completed a $50 million round of equity financing. The Kentucky drug maker will use the money for development and commercialization efforts, CEO Michael Valentino said.

Most of the nation’s large tobacco companies sued the U.S. Food and Drug Administration and U.S. Department of Health and Human Services on Monday saying a new federal law limits their freedom of speech. In 2001, the Supreme Court rejected outdoor advertising restrictions in tobacco regulations in Massachusetts, ruling that it violated free speech rights.

A federal jury in Frankfort, Ky., on Friday convicted two disbarred attorneys accused of scamming their clients out of millions of dollars from a diet-drug settlement.

Norton Healthcare hopes its proposed neurological institute will within five years make the health system one of the Top 10 neuroscience practices in the country.